52 results
F-1
EX-3.1
SCNI
Scinai Immunotherapeutics Ltd
30 Oct 23
Registration statement (foreign)
4:59pm
in the Company’s equity bears equal rights, for all intents and purposes, compared to any other Ordinary Share, including the right to a dividend, bonus … of bonus shares.
Determine that the owners of share fractions will not be entitled to receive a whole share for a share fraction.
Determine
6-K
SCNI
Scinai Immunotherapeutics Ltd
24 Aug 23
Report of Foreign Private Issuer
4:05pm
taking abstentions into account.
Proposal 9: Approval of a cash bonus for 2022 for Mark Germain, Chairman of the Board of Directors.
The shareholders … approved a cash bonus for 2022 for Mark Germain, Chairman of the Board of Directors:
FOR
AGAINST
ABSTAIN
The total number of votes of the holders
6-K
EX-99.1
SCNI
Scinai Immunotherapeutics Ltd
12 Jul 23
Report of Foreign Private Issuer
12:00am
Reichman, Chief Executive Officer of the Company, as Mr. Reichman’s long-term incentive grant award for 2022.
To approve a cash bonus for 2022 for Mark … units to Amir Reichman, Chief Executive Officer of the Company, as Mr. Reichman’s long-term incentive grant award for 2022.
To approve a cash bonus
6-K
EX-99.1
SCNI
Scinai Immunotherapeutics Ltd
5 Jul 23
Report of Foreign Private Issuer
9:17am
, Chief Executive Officer of the Company, as Mr. Reichman’s long-term incentive grant award for 2022.
To approve a cash bonus for 2022 for Mark Germain
10-K
2022 FY
EX-3.1
SCNI
Scinai Immunotherapeutics Ltd
17 Apr 23
Annual report
4:06pm
in the Company’s equity bears equal rights, for all intents and purposes, compared to any other Ordinary Share, including the right to a dividend, bonus shares … owed for the shares allotted as stated in article 35.2 will be redeemed, including the manner in which the sums can be redeemed on account of bonus
10-K
6iov4oci
17 Apr 23
Annual report
4:06pm
424B4
gbg18iiimoput8r814
20 Dec 22
Prospectus supplement with pricing info
11:59am
F-1/A
EX-3.1
io46etyt vtxohwj
14 Dec 22
Registration statement (foreign) (amended)
4:45pm
F-1/A
chfdfx8sn 5nmv2mf
12 Dec 22
Registration statement (foreign) (amended)
5:25pm
F-1
rlfvcnt csb7unkxej
29 Sep 22
Registration statement (foreign)
9:22am
6-K
alnj hxp7egc5l
18 May 22
Report of Foreign Private Issuer
6:27am
6-K
EX-99.1
yloi9z wtmr
12 Apr 22
Report of Foreign Private Issuer
4:15pm
6-K
EX-99.1
07wbpi
8 Apr 22
Report of Foreign Private Issuer
8:00am
6-K
EX-99.1
gaikd
4 Apr 22
Report of Foreign Private Issuer
7:08am
424B5
cv0m21ri
28 Dec 21
Prospectus supplement for primary offering
5:20pm
424B5
9qfejrx cnca512bz
27 Dec 21
Prospectus supplement for primary offering
6:22am
6-K
EX-99.1
xvvyz9uc
22 Nov 21
Report of Foreign Private Issuer
6:05am